Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| Director | Ciongoli Gregory Austin | Aug 27, 2026 | Buy | $499.68K | 53,407 |
| Director | Ciongoli Gregory Austin | Aug 26, 2026 | Buy | $449.71K | 49,196 |
| Chief Medical Officer | PAKOLA STEVE | Jul 2, 2026 | Sell | $29.48K | 2,161 |
| Chief Medical Officer | PAKOLA STEVE | Jul 1, 2026 | Sell | $472.28K | 36,725 |
| Chief Medical Officer | PAKOLA STEVE | Jun 29, 2026 | Sell | $216.47K | 19,608 |
| Chief Medical Officer | PAKOLA STEVE | May 11, 2026 | Sell | $168.71K | 15,309 |
| Chief Medical Officer | PAKOLA STEVE | Mar 10, 2026 | Sell | $53.03K | 5,124 |
| CEO | Simpson Curran | Oct 9, 2025 | Sell | $262.63K | 20,811 |
| CEO | Simpson Curran | Sep 29, 2025 | Sell | $76.47K | 7,624 |
| CEO | Simpson Curran | Sep 10, 2025 | Sell | $77.49K | 7,734 |
| Director | Mills Kenneth T. | May 12, 2025 | Sell | $163.05K | 20,602 |
| Director | KARABELAS ARGERIS N | Oct 1, 2024 | Sell | $101.05K | 10,000 |
| Director | KARABELAS ARGERIS N | Sep 3, 2024 | Sell | $106.95K | 9,300 |
| Director | KARABELAS ARGERIS N | Sep 3, 2024 | Sell | $8.64K | 700 |
| CEO | Simpson Curran | Aug 1, 2024 | Sell | $1.5K | 100 |
| Director | KARABELAS ARGERIS N | Aug 1, 2024 | Sell | $129.12K | 9,600 |
| Director | KARABELAS ARGERIS N | Aug 1, 2024 | Sell | $5.83K | 400 |
| Director | KARABELAS ARGERIS N | Aug 1, 2024 | Sell | $1.5K | 100 |
| CEO | Simpson Curran | Jul 29, 2024 | Sell | $145.11K | 9,648 |
| Director | KARABELAS ARGERIS N | Jul 29, 2024 | Sell | $165.5K | 11,000 |
| Director | Mills Kenneth T. | Jul 25, 2024 | Sell | $214.5K | 15,369 |
| Director | Mills Kenneth T. | Jul 24, 2024 | Sell | $168.43K | 12,221 |
| Director | Mills Kenneth T. | Jul 17, 2024 | Sell | $30.44K | 2,210 |
| Director | Mills Kenneth T. | Jul 16, 2024 | Sell | $2.75K | 200 |
| Director | KARABELAS ARGERIS N | Jul 1, 2024 | Sell | $112.69K | 10,000 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.
